Pharmaceutical Analytical Testing Outsourcing - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509243966

Publication Date:

September 20, 2024

Pages:

105

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Pharmaceutical Analytical Testing Outsourcing was estimated to be worth US$ 4508.4 million in 2023 and is forecast to a readjusted size of US$ 6972.8 million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Analytical Testing Outsourcing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharmaceutical Analytical Testing Outsourcing by region & country, by Type, and by Application.
The Pharmaceutical Analytical Testing Outsourcing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Analytical Testing Outsourcing.
麻豆原创 Segmentation
By Company
SGS SA (Switzerland)
Toxikon, Inc. (US)
Eurofins Scientific (Luxembourg)
Pharmaceutical Product Development, LLC (US)
Intertek Group plc (UK)
Pace Analytical Services, LLC (US)
Exova Group plc (UK)
Boston Analytical (US)
Charles River Laboratories International Inc. (US)
West Pharmaceutical Services, Inc. (US)
Segment by Type:
Bioanalytical Testing
Method Development & Validation
Stability Testing
Others
Segment by Application
Small & Medium Enterprise
Large Enterprise
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharmaceutical Analytical Testing Outsourcing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Pharmaceutical Analytical Testing Outsourcing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Pharmaceutical Analytical Testing Outsourcing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Pharmaceutical Analytical Testing Outsourcing Product Introduction
1.2 Global Pharmaceutical Analytical Testing Outsourcing 麻豆原创 Size Forecast
1.3 Pharmaceutical Analytical Testing Outsourcing 麻豆原创 Trends & Drivers
1.3.1 Pharmaceutical Analytical Testing Outsourcing Industry Trends
1.3.2 Pharmaceutical Analytical Testing Outsourcing 麻豆原创 Drivers & Opportunity
1.3.3 Pharmaceutical Analytical Testing Outsourcing 麻豆原创 Challenges
1.3.4 Pharmaceutical Analytical Testing Outsourcing 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical Analytical Testing Outsourcing Players Revenue Ranking (2023)
2.2 Global Pharmaceutical Analytical Testing Outsourcing Revenue by Company (2019-2024)
2.3 Key Companies Pharmaceutical Analytical Testing Outsourcing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Pharmaceutical Analytical Testing Outsourcing Product Offered
2.5 Key Companies Time to Begin Mass Production of Pharmaceutical Analytical Testing Outsourcing
2.6 Pharmaceutical Analytical Testing Outsourcing 麻豆原创 Competitive Analysis
2.6.1 Pharmaceutical Analytical Testing Outsourcing 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Pharmaceutical Analytical Testing Outsourcing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Analytical Testing Outsourcing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Bioanalytical Testing
3.1.2 Method Development & Validation
3.1.3 Stability Testing
3.1.4 Others
3.2 Global Pharmaceutical Analytical Testing Outsourcing Sales Value by Type
3.2.1 Global Pharmaceutical Analytical Testing Outsourcing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pharmaceutical Analytical Testing Outsourcing Sales Value, by Type (2019-2030)
3.2.3 Global Pharmaceutical Analytical Testing Outsourcing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Small & Medium Enterprise
4.1.2 Large Enterprise
4.2 Global Pharmaceutical Analytical Testing Outsourcing Sales Value by Application
4.2.1 Global Pharmaceutical Analytical Testing Outsourcing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pharmaceutical Analytical Testing Outsourcing Sales Value, by Application (2019-2030)
4.2.3 Global Pharmaceutical Analytical Testing Outsourcing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Pharmaceutical Analytical Testing Outsourcing Sales Value by Region
5.1.1 Global Pharmaceutical Analytical Testing Outsourcing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pharmaceutical Analytical Testing Outsourcing Sales Value by Region (2019-2024)
5.1.3 Global Pharmaceutical Analytical Testing Outsourcing Sales Value by Region (2025-2030)
5.1.4 Global Pharmaceutical Analytical Testing Outsourcing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Pharmaceutical Analytical Testing Outsourcing Sales Value, 2019-2030
5.2.2 North America Pharmaceutical Analytical Testing Outsourcing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Pharmaceutical Analytical Testing Outsourcing Sales Value, 2019-2030
5.3.2 Europe Pharmaceutical Analytical Testing Outsourcing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Sales Value, 2019-2030
5.4.2 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Pharmaceutical Analytical Testing Outsourcing Sales Value, 2019-2030
5.5.2 South America Pharmaceutical Analytical Testing Outsourcing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Sales Value, 2019-2030
5.6.2 Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical Analytical Testing Outsourcing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pharmaceutical Analytical Testing Outsourcing Sales Value
6.3 United States
6.3.1 United States Pharmaceutical Analytical Testing Outsourcing Sales Value, 2019-2030
6.3.2 United States Pharmaceutical Analytical Testing Outsourcing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pharmaceutical Analytical Testing Outsourcing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pharmaceutical Analytical Testing Outsourcing Sales Value, 2019-2030
6.4.2 Europe Pharmaceutical Analytical Testing Outsourcing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pharmaceutical Analytical Testing Outsourcing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pharmaceutical Analytical Testing Outsourcing Sales Value, 2019-2030
6.5.2 China Pharmaceutical Analytical Testing Outsourcing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pharmaceutical Analytical Testing Outsourcing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pharmaceutical Analytical Testing Outsourcing Sales Value, 2019-2030
6.6.2 Japan Pharmaceutical Analytical Testing Outsourcing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pharmaceutical Analytical Testing Outsourcing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pharmaceutical Analytical Testing Outsourcing Sales Value, 2019-2030
6.7.2 South Korea Pharmaceutical Analytical Testing Outsourcing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pharmaceutical Analytical Testing Outsourcing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical Analytical Testing Outsourcing Sales Value, 2019-2030
6.8.2 Southeast Asia Pharmaceutical Analytical Testing Outsourcing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pharmaceutical Analytical Testing Outsourcing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pharmaceutical Analytical Testing Outsourcing Sales Value, 2019-2030
6.9.2 India Pharmaceutical Analytical Testing Outsourcing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pharmaceutical Analytical Testing Outsourcing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 SGS SA (Switzerland)
7.1.1 SGS SA (Switzerland) Profile
7.1.2 SGS SA (Switzerland) Main Business
7.1.3 SGS SA (Switzerland) Pharmaceutical Analytical Testing Outsourcing Products, Services and Solutions
7.1.4 SGS SA (Switzerland) Pharmaceutical Analytical Testing Outsourcing Revenue (US$ Million) & (2019-2024)
7.1.5 SGS SA (Switzerland) Recent Developments
7.2 Toxikon, Inc. (US)
7.2.1 Toxikon, Inc. (US) Profile
7.2.2 Toxikon, Inc. (US) Main Business
7.2.3 Toxikon, Inc. (US) Pharmaceutical Analytical Testing Outsourcing Products, Services and Solutions
7.2.4 Toxikon, Inc. (US) Pharmaceutical Analytical Testing Outsourcing Revenue (US$ Million) & (2019-2024)
7.2.5 Toxikon, Inc. (US) Recent Developments
7.3 Eurofins Scientific (Luxembourg)
7.3.1 Eurofins Scientific (Luxembourg) Profile
7.3.2 Eurofins Scientific (Luxembourg) Main Business
7.3.3 Eurofins Scientific (Luxembourg) Pharmaceutical Analytical Testing Outsourcing Products, Services and Solutions
7.3.4 Eurofins Scientific (Luxembourg) Pharmaceutical Analytical Testing Outsourcing Revenue (US$ Million) & (2019-2024)
7.3.5 Pharmaceutical Product Development, LLC (US) Recent Developments
7.4 Pharmaceutical Product Development, LLC (US)
7.4.1 Pharmaceutical Product Development, LLC (US) Profile
7.4.2 Pharmaceutical Product Development, LLC (US) Main Business
7.4.3 Pharmaceutical Product Development, LLC (US) Pharmaceutical Analytical Testing Outsourcing Products, Services and Solutions
7.4.4 Pharmaceutical Product Development, LLC (US) Pharmaceutical Analytical Testing Outsourcing Revenue (US$ Million) & (2019-2024)
7.4.5 Pharmaceutical Product Development, LLC (US) Recent Developments
7.5 Intertek Group plc (UK)
7.5.1 Intertek Group plc (UK) Profile
7.5.2 Intertek Group plc (UK) Main Business
7.5.3 Intertek Group plc (UK) Pharmaceutical Analytical Testing Outsourcing Products, Services and Solutions
7.5.4 Intertek Group plc (UK) Pharmaceutical Analytical Testing Outsourcing Revenue (US$ Million) & (2019-2024)
7.5.5 Intertek Group plc (UK) Recent Developments
7.6 Pace Analytical Services, LLC (US)
7.6.1 Pace Analytical Services, LLC (US) Profile
7.6.2 Pace Analytical Services, LLC (US) Main Business
7.6.3 Pace Analytical Services, LLC (US) Pharmaceutical Analytical Testing Outsourcing Products, Services and Solutions
7.6.4 Pace Analytical Services, LLC (US) Pharmaceutical Analytical Testing Outsourcing Revenue (US$ Million) & (2019-2024)
7.6.5 Pace Analytical Services, LLC (US) Recent Developments
7.7 Exova Group plc (UK)
7.7.1 Exova Group plc (UK) Profile
7.7.2 Exova Group plc (UK) Main Business
7.7.3 Exova Group plc (UK) Pharmaceutical Analytical Testing Outsourcing Products, Services and Solutions
7.7.4 Exova Group plc (UK) Pharmaceutical Analytical Testing Outsourcing Revenue (US$ Million) & (2019-2024)
7.7.5 Exova Group plc (UK) Recent Developments
7.8 Boston Analytical (US)
7.8.1 Boston Analytical (US) Profile
7.8.2 Boston Analytical (US) Main Business
7.8.3 Boston Analytical (US) Pharmaceutical Analytical Testing Outsourcing Products, Services and Solutions
7.8.4 Boston Analytical (US) Pharmaceutical Analytical Testing Outsourcing Revenue (US$ Million) & (2019-2024)
7.8.5 Boston Analytical (US) Recent Developments
7.9 Charles River Laboratories International Inc. (US)
7.9.1 Charles River Laboratories International Inc. (US) Profile
7.9.2 Charles River Laboratories International Inc. (US) Main Business
7.9.3 Charles River Laboratories International Inc. (US) Pharmaceutical Analytical Testing Outsourcing Products, Services and Solutions
7.9.4 Charles River Laboratories International Inc. (US) Pharmaceutical Analytical Testing Outsourcing Revenue (US$ Million) & (2019-2024)
7.9.5 Charles River Laboratories International Inc. (US) Recent Developments
7.10 West Pharmaceutical Services, Inc. (US)
7.10.1 West Pharmaceutical Services, Inc. (US) Profile
7.10.2 West Pharmaceutical Services, Inc. (US) Main Business
7.10.3 West Pharmaceutical Services, Inc. (US) Pharmaceutical Analytical Testing Outsourcing Products, Services and Solutions
7.10.4 West Pharmaceutical Services, Inc. (US) Pharmaceutical Analytical Testing Outsourcing Revenue (US$ Million) & (2019-2024)
7.10.5 West Pharmaceutical Services, Inc. (US) Recent Developments
8 Industry Chain Analysis
8.1 Pharmaceutical Analytical Testing Outsourcing Industrial Chain
8.2 Pharmaceutical Analytical Testing Outsourcing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pharmaceutical Analytical Testing Outsourcing Sales Model
8.5.2 Sales Channel
8.5.3 Pharmaceutical Analytical Testing Outsourcing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

SGS SA (Switzerland)
Toxikon, Inc. (US)
Eurofins Scientific (Luxembourg)
Pharmaceutical Product Development, LLC (US)
Intertek Group plc (UK)
Pace Analytical Services, LLC (US)
Exova Group plc (UK)
Boston Analytical (US)
Charles River Laboratories International Inc. (US)
West Pharmaceutical Services, Inc. (US)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.